Open AccessSafety and Efficacy of Dupilumab for the Treatment of Hospitalized Patients With Moderate to Severe Coronavirus Disease 2019: A Phase 2a Trial
Author(s) -
Jennifer Sasson,
Alexandra N. Donlan,
Z. Jennie,
Heather M. Haughey,
Rachael Coleman,
Uma Nayak,
Amy J. Mathers,
Sylvain Laverdure,
Robin Dewar,
Patrick E. H. Jackson,
Scott K. Heysell,
Jeffrey M. Sturek,
William A. Petri
Publication year - 2022
Publication title -
open forum infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.546
H-Index - 35
ISSN - 2328-8957
DOI - 10.1093/ofid/ofac343
Subject(s) - medicine , clinical endpoint , dupilumab , placebo , hazard ratio , adverse effect , randomized controlled trial , randomization , intensive care unit , exacerbation , confidence interval , pathology , alternative medicine , asthma
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom